Old Web
English
Sign In
Acemap
>
authorDetail
>
Qian Qiao
Qian Qiao
Chinese PLA General Hospital
anti pd 1
first line therapy
Hepatocellular carcinoma
Medicine
Oncology
2
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Penpulimab (Anti-PD-1) combined with anlotinib as first-line therapy for unresectable hepatocellular carcinoma (uHCC): Updated results from a phase Ib/II study.
2021
Journal of Clinical Oncology
Shunchang Jiao
Li Bai
Jiahong Dong
Chunmei Bai
Chunhong Hu
Liangfang Shen
Qun Qin
Yuxian Bai
Jia Fan
Aimin Zang
Yanyun Zhu
Chun Han
Juan Li
Pengfei Zhang
Sisi Ye
Xindan Kang
Qian Qiao
Zhongmin Maxwell Wang
Baiyong Li
Yu Xia
Show All
Source
Cite
Save
Citations (0)
Clinical activity and safety of penpulimab (Anti-PD-1) with anlotinib as first-line therapy for advanced hepatocellular carcinoma (HCC).
2020
Journal of Clinical Oncology
Shunchang Jiao
Li Bai
Jiahong Dong
Chunmei Bai
Chunhong Hu
Liangfang Shen
Qun Qin
Yuxian Bai
Jia Fan
Aimin Zang
Chun Han
Yanyun Zhu
Juan Li
Pengfei Zhang
Sisi Ye
Xindan Kang
Qian Qiao
Weifeng Song
Baiyong Li
Yu Xia
Show All
Source
Cite
Save
Citations (3)
1